AVIRAtea Pharmaceuticals, Inc.

$484M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$17,000

Operating Income

-$15M

Net Income

-$13M

EPS (Diluted)

$-0.16

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$624,000

Balance Sheet

Total Assets

$22M

Total Liabilities

$3M

Stockholders' Equity

$20M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$17,000	-$17,000	+0.0%
Operating Income	-$15M	-$9M	-54.1%
Net Income	-$13M	-$9M	-48.5%

AVIR FY 2019 Earnings — Atea Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena